MedPath

Exploring the Psychophysics of Keratoconus Using the Moorfields Acuity Chart

Not Applicable
Completed
Conditions
Keratoconic Subjects
Interventions
Device: Moorfields Acuity Chart
Registration Number
NCT02429609
Lead Sponsor
Moorfields Eye Hospital NHS Foundation Trust
Brief Summary

The measurement of visual acuity is made using black letters of varying size superimposed on a uniform white background. The objective is to determine the smallest letter, or optotype, that can be correctly identified. One limitation of current tests is the variability of measurements, this making it difficult for clinicians to determine if changes in visual acuity are related to ocular disease. This variability has been attributed to the design of current optotypes, in particular their differing legibilities. Our group has recently demonstrated that a new type of letter chart (Moorfields Acuity Chart), containing letters with a black core and a white border presented on a grey background, reduces the variability of visual acuity measurements. In this study the investigators wish to determine if changes in vision owing to keratoconus, a disease that causes the cornea to adopt an irregular shape, may be detected more easily using the Moorfields Acuity Chart compared with conventional letter charts.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Keratoconic subjectsMoorfields Acuity Chart1. Short clinical interview (Questions pertaining to ocular and systemic health, medications, family history and date of birth). (approx. 2 minutes) 2. Visual acuity measurement using EDTRS chart at 4 m (approx. 4 minutes) 3. Refraction: retinoscopy and subjective, at 4m (approx. 10 minutes) 4. Anterior eye examination (approx. 4 minutes) 5. Fundus examination using binocular indirect ophthalmoscopy or a standard ophthalmoscope - to screen for eye disease that is likely to affect visual ability in this study. (approx. 5 minutes) 6. Corneal topography measurement with an Oculus Pentacam (Oculus Gmbh., Germany). (approx. 5 minutes) Two measurements of visual acuity will be made: 1. Standard ETDRS logMAR acuity measurement (5 minutes) 2. Vanishing Optotype logMAR acuity measurement (5 minutes)
Healthy subjectsMoorfields Acuity Chart1. Short clinical interview (Questions pertaining to ocular and systemic health, medications, family history and date of birth). (approx. 2 minutes) 2. Visual acuity measurement using EDTRS chart at 4 m (approx. 4 minutes) 3. Refraction: retinoscopy and subjective, at 4m (approx. 10 minutes) 4. Anterior eye examination (approx. 4 minutes) 5. Fundus examination using binocular indirect ophthalmoscopy or a standard ophthalmoscope - to screen for eye disease that is likely to affect visual ability in this study. (approx. 5 minutes) 6. Corneal topography measurement with an Oculus Pentacam (Oculus Gmbh., Germany). (approx. 5 minutes) Two measurements of visual acuity will be made: 1. Standard ETDRS logMAR acuity measurement (5 minutes) 2. Vanishing Optotype logMAR acuity measurement (5 minutes)
Primary Outcome Measures
NameTimeMethod
The relative difference in visual acuity measurement between subjects with and without keratoconus when examined with different types of visual acuity chart.9 months
Secondary Outcome Measures
NameTimeMethod
The relationship (if any) between optical imperfections (high order aberrations) and measurements of visual acuity when measured using different test chart designs.9 months
© Copyright 2025. All Rights Reserved by MedPath